LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
Phase of Trial: Phase 0
Latest Information Update: 03 Oct 2019
Price : $35 *
At a glance
- Drugs Glucarpidase (Primary) ; Folinic acid; Methotrexate; Rituximab
- Indications B-cell lymphoma; Chemotherapy-induced damage; CNS cancer; Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- 27 Sep 2019 Planned number of patients changed from 24 to 12.
- 29 Jul 2019 Planned number of patients changed from 6 to 24.
- 26 Mar 2019 Planned End Date changed from 1 Oct 2019 to 1 Oct 2020.